4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-031055
Director sold 7,500 shares at $74.65 ($559,875)
- Director acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Aliski William · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-18 | Exercise or conversion : show line 1 in the form | +7,500 | $40.37 | $302,775 | 55,424 | D |
| 2020-05-18 | Sale : show line 2 in the form | −7,500 | $74.65 | $559,875 | 47,924 | D |
| Open-market sales · 7,500 sh · avg $74.65 · $559,875 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-05-18 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,500 | $40.37 | 2024-07-10 | 7,500 | 0 | D |
Loading xslF345X03/doc4.xml…